Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2026-01-02 Transaction in Own Shar…
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the number of shares purchased, the price paid, and the impact on total voting rights. Additionally, it includes a mandatory disclosure for a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically a Non-Executive Director. While it contains PDMR information, the primary purpose of the filing is to report the company's transaction in its own shares (buyback). Therefore, it is classified as a Transaction in Own Shares (POS).
2026-01-02 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program and a related PDMR (Person Discharging Managerial Responsibilities) transaction. It details the purchase of 43,000 ordinary shares to be held in treasury and includes the mandatory disclosure form for a director's (Christopher Mills) disposal of shares. While it contains PDMR information, the primary corporate action is the company's own share repurchase. According to the filing definitions, 'Transaction in Own Shares' (POS) is the most specific category for company share buybacks.
2025-12-31 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the number of shares purchased, the price paid, and the impact on total voting rights. It also includes a section on PDMR (Person Discharging Managerial Responsibilities) dealing, which is a standard component of share repurchase announcements when directors are involved. Since the primary purpose of the document is to report the company's purchase of its own shares, it falls under the 'Transaction in Own Shares' category.
2025-12-30 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding a share buyback program. It details the purchase of 71,000 ordinary shares, provides transaction specifics (price, volume, venue), and includes a mandatory PDMR (Person Discharging Managerial Responsibilities) disclosure form for a director's share disposal. Since the primary purpose of the document is to report the company's repurchase of its own shares, it falls under the 'Transaction in Own Shares' category.
2025-12-29 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding the purchase of its own shares (share buyback) and includes a mandatory PDMR (Person Discharging Managerial Responsibilities) dealing disclosure. While it contains PDMR information, the primary corporate action described is the company buying back its own shares, which aligns with the 'Transaction in Own Shares' (POS) category. The document follows the standard RNS format for such disclosures.
2025-12-24 English
Share Buyback
Transaction in Own Shares Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC regarding the purchase of its own shares (share buyback) and includes a PDMR (Person Discharging Managerial Responsibilities) dealing notification. According to the filing definitions, 'Transaction in Own Shares' (POS) is the specific category for company share buybacks, and the document provides the required aggregated and detailed trade information.
2025-12-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.